(Q37419056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

review article

1 reference

title

Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

0 references

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Robert H Goertsches

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Uwe K Zettl

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 December 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

255 Suppl 6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

48-57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-008-6010-1

24 January 2020

exact match

0 references

cites work

Genome-wide network analysis reveals the global properties of IFN-beta immediate transcriptional effects in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6010-1

Neutralizing antibodies to interferon beta-1b are not associated with disease worsening in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6010-1

A network analysis of the human T-cell activation gene network identifies JAGGED1 as a therapeutic target for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6010-1

Clinical characteristics of responders to interferon therapy for relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6010-1

Genomic effects of IFN-beta in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-008-6010-1

The immunopathogenesis of multiple sclerosis

21 January 2018

1 reference

12 December 2020

Defining interferon beta response status in multiple sclerosis patients.

1 reference

12 December 2020

Predictors of long-term clinical response to interferon beta therapy in relapsing multiple sclerosis.

1 reference

12 December 2020

Interferon-beta directly influences monocyte infiltration into the central nervous system.

1 reference

12 December 2020

Cluster analysis and display of genome-wide expression patterns

1 reference

12 December 2020

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

12 December 2020

Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells

1 reference

12 December 2020

Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy

1 reference

12 December 2020

Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes.

1 reference

12 December 2020

Cytoscape: a software environment for integrated models of biomolecular interaction networks

1 reference

12 December 2020

Gene microarrays and experimental demyelinating disease: a tool to enhance serendipity.

1 reference

12 December 2020

Copy number variants and genetic traits: closer to the resolution of phenotypic to genotypic variability

1 reference

12 December 2020

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

1 reference

12 December 2020

Functional classification of interferon-stimulated genes identified using microarrays

1 reference

12 December 2020

Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.

1 reference

12 December 2020

COPASI--a COmplex PAthway SImulator

1 reference

12 December 2020

Genomics in multiple sclerosis--current state and future directions.

1 reference

12 December 2020

IFN-beta-regulated genes show abnormal expression in therapy-naïve relapsing-remitting MS mononuclear cells: gene expression analysis employing all reported protein-protein interactions

1 reference

12 December 2020

Charting protein complexes, signaling pathways, and networks in the immune system

1 reference

12 December 2020

Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis.

1 reference

12 December 2020

Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis

1 reference

12 December 2020

Interferons at age 50: past, current and future impact on biomedicine

1 reference

12 December 2020

Gene expression profiles reveal homeostatic dynamics during interferon-beta therapy in multiple sclerosis

1 reference

12 December 2020

Transcription-based prediction of response to IFNbeta using supervised computational methods

1 reference

12 December 2020

An array of possibilities for multiple sclerosis

1 reference

12 December 2020

Systems biology approaches for the study of multiple sclerosis

1 reference

12 December 2020

Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis

1 reference

12 December 2020

Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation

1 reference

12 December 2020

Interferon-beta treatment alters peripheral blood monocytes chemokine production in MS patients

1 reference

12 December 2020

Dynamics of immune cell trafficking in interferon-beta treated multiple sclerosis patients

1 reference

12 December 2020

Novel interferon-beta-induced gene expression in peripheral blood cells.

1 reference

12 December 2020

T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients

1 reference

12 December 2020

Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis

1 reference

12 December 2020

Understanding autoimmune mechanisms in multiple sclerosis using gene expression microarrays: treatment effect and cytokine-related pathways.

1 reference

12 December 2020

The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease

1 reference

12 December 2020

Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy

1 reference

12 December 2020

Cellular responses to interferon-gamma

1 reference

12 December 2020

A network-based analysis of systemic inflammation in humans

1 reference

12 December 2020

Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFNbeta-responsive genes in peripheral blood lymphocytes in vitro: an implication for IFNbeta-related adverse effects in multiple sclerosis

1 reference

12 December 2020

IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression.

1 reference

12 December 2020

How cells respond to interferons

1 reference

12 December 2020

The future of genomic profiling of neurological diseases using blood

1 reference

12 December 2020

Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis.

1 reference

12 December 2020

Pharmacogenomics of Type I interferon therapy: a survey of response-modifying genes

1 reference

12 December 2020

A data integration methodology for systems biology

1 reference

12 December 2020

Gene ontology: tool for the unification of biology

1 reference

12 December 2020

The genetics of multiple sclerosis: SNPs to pathways to pathogenesis

1 reference

12 December 2020

Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers.

1 reference

12 December 2020

10.1007/S00415-008-6010-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19300960%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference